CIK: 0001082621 · Show all filings
Period: Q1 2019 (← Previous) (Next →)
Filing Date: May 10, 2019
Total Value ($000): $394,136 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AAPL | APPLE INC | 870,051 | $165,266 | 41.9% | $45.43 | -11.0% | COM | 037833100 |
| GOOGL | ALPHABET INC | 74,537 | $87,722 | 22.3% | $54.61 | +2.6% | CAP STK CL A | 02079K305 |
| META | FACEBOOK INC | 306,399 | $51,074 | 13.0% | $175.16 | -9.8% | CL A | 30303M102 |
| IVV | ISHARES TR | 73,214 | $20,834 | 5.3% | $169.98 | — | CORE S&P500 ETF | 464287200 |
| VEA | VANGUARD TAX MANAGED INTL FD | 329,167 | $13,453 | 3.4% | $35.82 | — | FTSE DEV MKT ETF | 921943858 |
| GLD | SPDR GOLD TRUST | 104,165 | $12,715 | 3.2% | $118.28 | — | GOLD SHS | 78463V107 |
| QQQ | INVESCO QQQ TR | 46,014 | $8,267 | 2.1% | $172.05 | — | UNIT SER 1 | 46090E103 |
| VWO | VANGUARD INTL EQUITY INDEX F | 187,728 | $7,978 | 2.0% | $46.12 | — | FTSE EMR MKT ETF | 922042858 |
| EDV | VANGUARD WORLD FD | 47,313 | $5,638 | 1.4% | $114.12 | — | EXTENDED DUR | 921910709 |
| — | MAGENTA THERAPEUTICS INC | 332,610 | $5,478 | 1.4% | $12.01 | — | COM | 55910K108 |
| IJH | ISHARES TR | 26,759 | $5,068 | 1.3% | $124.12 | — | CORE S&P MCP ETF | 464287507 |
| IJR | ISHARES TR | 58,484 | $4,512 | 1.1% | $69.16 | — | CORE S&P SCP ETF | 464287804 |
| — | NEON THERAPEUTICS INC | 505,871 | $3,268 | 0.8% | $12.60 | — | COM | 64050Y100 |
| — | ADURO BIOTECH INC | 640,595 | $2,550 | 0.6% | $10.65 | — | COM | 00739L101 |
| VIG | VANGUARD GROUP | 2,858 | $313 | 0.1% | $66.20 | — | DIV APP ETF | 921908844 |